CN109045066A - 一种复合碘伏消毒液及其制备方法 - Google Patents
一种复合碘伏消毒液及其制备方法 Download PDFInfo
- Publication number
- CN109045066A CN109045066A CN201811263777.1A CN201811263777A CN109045066A CN 109045066 A CN109045066 A CN 109045066A CN 201811263777 A CN201811263777 A CN 201811263777A CN 109045066 A CN109045066 A CN 109045066A
- Authority
- CN
- China
- Prior art keywords
- parts
- iodine
- isopropanol
- potassium iodide
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/18—Iodine; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
本发明是一种复合碘伏消毒液及其制备方法,原料按重量份数如下:碘0.5‑1份,碘化钾0.5‑1份,聚乙烯吡咯烷酮6‑7份,烷基酚聚氧乙烯醚2‑3份,壳聚糖0.1‑0.5份,茶树油0.5‑1份,棕榈油0.1‑1份,失水山梨醇单硬脂酸酯0.1‑1份,异丙醇0.1‑1份,去离子水110‑125份。本发明在密闭不加热条件下进行,有效碘成分损失小,无废气、废液排放;工艺及操作简单,劳动强度小,自动化程度高,参数容易控制;可以有效提高配方含量及生产效率,效果非常明显,在制备工艺上有较大的发展潜力。
Description
技术领域
本发明涉及的药物开发技术、涉及对传统碘伏制剂生产工艺的改进,通过新工艺改善了传统碘伏生产过程的不良特性,降低生产成本、增项了碘伏的消毒效果以及增加了辅助功效。
背景技术
碘伏,在消毒行业中归类为含碘制剂,含碘制剂定义为以碘为主要杀菌成分的消毒剂,主要包括:碘酊、碘伏。碘伏定义为,碘与聚醇醚和聚乙烯吡咯烷酮类表面活性剂形成的络合物。
碘,本品为灰黑色或蓝黑色、有金属光泽的片状结晶或块状物,质重、脆、有特臭,在常温中能挥发。碘在乙醇、乙醚或二硫化碳中易溶,在三氯甲烷中溶解,在四氯化碳中略溶,在水中几乎不溶,在碘化钾或碘化钠的水溶液中溶解。是消毒防腐药。
碘化钾,为无色结晶或白色结晶性粉末,无臭,微有引湿性。碘化钾在水中极易溶解,在乙醇中溶解。是补碘药。
聚醇醚,聚醇醚是一类物质,此类物质为非离子表面活性剂,为粘合剂和助溶剂等。
聚维酮,本品为白色至乳白色粉末,无臭或稍有特臭,无味,具引湿性。聚维酮在水、乙醇、异丙醇或三氯甲烷中溶解,在丙酮或乙醚中不溶。药用辅料,黏合剂和助溶剂等。
根据传统碘伏主要原料的性质特征可以看出,目前市场上主流碘伏产品主要为醚碘和酮碘,其两种产品的生产工艺主要缺点为:醚碘生产工艺由于其使用原料的特性,缺点在于产品分散性不强、液体粘稠不宜涂抹均匀、产品稳定性差、刺激性强、黄染严重等;酮碘生产工艺由于其使用原料特性,缺点在于生产需通过络合技术,生产周期长、工艺复杂、所需设备多、易产生烟尘、投入人工多等。
发明内容
本发明目的是针对现有技术存在的不足,提供一种简单易行、络合效果更好的碘伏制备技术。
为实现本发明的目的,采用的技术方案是:一种碘伏消毒液,原料按重量份数如下:碘0.5-1份,碘化钾0.5-1份,聚乙烯吡咯烷酮6-7份,烷基酚聚氧乙烯醚2-3份,壳聚糖0.1-0.5份,茶树油0.5-1份,棕榈油0.1-1份,失水山梨醇单硬脂酸酯0.1-1份,异丙醇0.1-1份,去离子水110-125份。
本发明具有以下优点:
本发明涉及一种碘伏的制备方法,其特征在于所用设备简单且少,设备故障容易排除,设备可重复循环利用,减少设备投资,在密闭不加热条件下进行,有效碘成分损失小,无废气、废液排放;工艺及操作简单,劳动强度小,自动化程度高,参数容易控制;所有原料、溶液都可重复循环使用,减少原料成本,无废液、废渣排放,无环境污染。本发明的方法有效节省设备、原料、试剂及成本,无三废排放,节能、减排、环保、低成本,可以有效提高配方含量及生产效率,效果非常明显,在制备工艺上有较大的发展潜力。
在原有传统碘伏配方基础上,加入了壳聚糖、茶树油、棕榈油、失水山梨醇单硬脂酸酯、异丙醇、烷基酚聚氧乙烯醚进行配置,配置方法、性质表征及效果测试方法均包括在本发明中。
具体实施方式
下面结合实施例对本发明进一步说明。一种碘伏消毒液,原料按重量份数如下:
碘0.5-1份,碘化钾0.5-1份,聚乙烯吡咯烷酮6-7份,烷基酚聚氧乙烯醚2-3份,壳聚糖0.1-0.5份,茶树油0.5-1份,棕榈油0.1-1份,失水山梨醇单硬脂酸酯0.1-1份,异丙醇0.1-1份,去离子水110-125份。
碘0.91份,碘化钾0.91份,聚乙烯吡咯烷酮6.15份,烷基酚聚氧乙烯醚2.7份,壳聚糖0.35份,茶树油0.6份,棕榈油0.4份,失水山梨醇单硬脂酸酯0.15份,异丙醇0.1份,去离子水125份。
采用的制备方法是:
1)、将碘、碘化钾均匀搅拌3-5分钟,将混合物加入烷基酚聚氧乙烯醚中,再均匀搅拌2小时,制得混合物A;
2)、将失水山梨醇单硬脂酸酯、异丙醇加入去离子水中搅拌溶解,加入聚乙烯吡咯烷酮继续搅拌均匀,制成溶液B;
3)、将A和B混合搅拌0.5-1小时后一起密闭遮光放置24小时后再均匀搅拌1小时得C;
4)、在溶液C中加入壳聚糖、茶树油、棕榈油,搅拌0.5-1小时,制得碘伏消毒液。
实施例
本发明提供的一种碘伏消毒液,其原料按重量份包括:碘0.91份,碘化钾0.91份,聚乙烯吡咯烷酮6.15份,烷基酚聚氧乙烯醚2.7份,壳聚糖0.35份,茶树油0.6份,棕榈油0.4份,失水山梨醇单硬脂酸酯0.15份,异丙醇0.1份,去离子水125份。
1、将碘、碘化钾均匀搅拌3-5分钟,将混合物加入烷基酚聚氧乙烯醚中,再均匀搅拌2小时,制得混合物A;
2、将失水山梨醇单硬脂酸酯、异丙醇加入去离子水中搅拌溶解,加入聚乙烯吡咯烷酮继续搅拌均匀,制成溶液B;
3、将A和B混合搅拌0.5-1小时后一起密闭遮光放置24小时后再均匀搅拌1小时得C;
4、在溶液C中加入壳聚糖、茶树油、棕榈油,搅拌0.5-1小时,制得碘伏消毒液。
本发明具体技术指标见下表:
Claims (3)
1.一种碘伏消毒液,其特征在于:原料按重量份数如下:
碘0.5-1份,碘化钾0.5-1份,聚乙烯吡咯烷酮6-7份,烷基酚聚氧乙烯醚2-3份,壳聚糖0.1-0.5份,茶树油0.5-1份,棕榈油0.1-1份,失水山梨醇单硬脂酸酯0.1-1份,异丙醇0.1-1份,去离子水110-125份。
2.根据权利要求1所述的一种碘伏消毒液,其特征在于:原料按重量份数如下:
碘0.91份,碘化钾0.91份,聚乙烯吡咯烷酮6.15份,烷基酚聚氧乙烯醚2.7份,壳聚糖0.35份,茶树油0.6份,棕榈油0.4份,失水山梨醇单硬脂酸酯0.15份,异丙醇0.1份,去离子水125份。
3.根据权利要求1所述的一种碘伏消毒液的制备方法,其特征在于,包括如下步骤:
1)、将碘、碘化钾均匀搅拌3-5分钟,将混合物加入烷基酚聚氧乙烯醚中,再均匀搅拌2小时,制得混合物A;
2)、将失水山梨醇单硬脂酸酯、异丙醇加入去离子水中搅拌溶解,加入聚乙烯吡咯烷酮继续搅拌均匀,制成溶液B;
3)、将A和B混合搅拌0.5-1小时后一起密闭遮光放置24小时后再均匀搅拌1小时得C;
4)、在溶液C中加入壳聚糖、茶树油、棕榈油,搅拌0.5-1小时,制得碘伏消毒液。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811263777.1A CN109045066A (zh) | 2018-10-28 | 2018-10-28 | 一种复合碘伏消毒液及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811263777.1A CN109045066A (zh) | 2018-10-28 | 2018-10-28 | 一种复合碘伏消毒液及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109045066A true CN109045066A (zh) | 2018-12-21 |
Family
ID=64767896
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811263777.1A Pending CN109045066A (zh) | 2018-10-28 | 2018-10-28 | 一种复合碘伏消毒液及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109045066A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112933161A (zh) * | 2021-02-04 | 2021-06-11 | 贵州碘雅医疗器械有限公司 | 一种复合碘伏消毒液 |
CN113768874A (zh) * | 2021-09-16 | 2021-12-10 | 四川省伊洁士医疗科技有限公司 | 一种新型复合碘消毒液及其制备方法 |
CN115212272A (zh) * | 2022-06-14 | 2022-10-21 | 河南天厚医疗科技有限公司 | 一种复合碘伏消毒液及其制备方法 |
-
2018
- 2018-10-28 CN CN201811263777.1A patent/CN109045066A/zh active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112933161A (zh) * | 2021-02-04 | 2021-06-11 | 贵州碘雅医疗器械有限公司 | 一种复合碘伏消毒液 |
CN113768874A (zh) * | 2021-09-16 | 2021-12-10 | 四川省伊洁士医疗科技有限公司 | 一种新型复合碘消毒液及其制备方法 |
CN115212272A (zh) * | 2022-06-14 | 2022-10-21 | 河南天厚医疗科技有限公司 | 一种复合碘伏消毒液及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109045066A (zh) | 一种复合碘伏消毒液及其制备方法 | |
Gan et al. | Green synthesis of gold nanoparticles using palm oil mill effluent (POME): a low-cost and eco-friendly viable approach | |
Zapór | Effects of silver nanoparticles of different sizes on cytotoxicity and oxygen metabolism disorders in both reproductive and respiratory system cells | |
CN106986432B (zh) | 重金属捕捉剂 | |
CN108002509A (zh) | 一种水产养殖底质改良用片剂及其制备方法 | |
CN103773616A (zh) | 一种冲版机专用除垢剂及其制备方法 | |
CN108379765A (zh) | 一种重金属螯合剂及其制备方法 | |
CN102173602A (zh) | 一种经表面处理的玻璃纤维、制备方法及应用 | |
CN108017724B (zh) | 一种植物源性壳聚糖的制备方法 | |
CN103936119A (zh) | 聚硅酸氯化铝铁/荧光增白剂复合蓝藻处理剂及其制作方法 | |
CN109776869A (zh) | 一种氧化纳米纤维素固定化纳米银/葡萄籽提取物抗菌、抗氧化复合膜、制备方法及应用 | |
CN103694599A (zh) | 一种高效、环保聚氯乙烯热稳定剂及其制备方法 | |
JP2016121251A (ja) | 六価クロム低減剤 | |
CN109355666A (zh) | 一种碳钢酸洗缓蚀剂及其制备方法和应用 | |
CN104387830A (zh) | 一种建筑腻子粉及其制备方法 | |
CN105154092B (zh) | 一种土壤重金属钝化剂及其制备方法 | |
CN105692767B (zh) | 一种含有凹凸棒土的涂装水处理剂及其制备方法 | |
CN103964732B (zh) | 提高水泥与混凝土适应性的液体水泥助磨剂及其制备方法 | |
CN106242212A (zh) | 一种高效含油污泥处理剂及其制备方法 | |
CN104328438B (zh) | 环保生物型水基防锈液 | |
CN104941995B (zh) | 一种针对铬污染土壤的修复方法 | |
CN104761739A (zh) | 一种可降解环保型包装膜的制备方法 | |
CN105454291A (zh) | 一种纳米银泡腾片杀菌剂及其制备方法 | |
CN109370603A (zh) | 一种猕猴桃种植的土壤改良剂及其制备方法 | |
CN107010708A (zh) | 一种海藻多糖硫酸酯包覆纳米零价铁及其制备方法与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20181221 |
|
WD01 | Invention patent application deemed withdrawn after publication |